We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$112B
AUM Growth
-$23.9B
Cap. Flow
-$21.6B
Cap. Flow %
-19.26%
Top 10 Hldgs %
10.96%
Holding
4,902
New
569
Increased
1,472
Reduced
1,734
Closed
704

Sector Composition

Rank Sector Weight
1 Technology 15.18%
2 Healthcare 9.91%
3 Consumer Discretionary 9.25%
4 Financials 6.45%
5 Industrials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNGX icon
3901
Tango Therapeutics
TNGX
$4.34B
$93.5K ﹤0.01%
68,269
-46,558
-41% -$114K
GPRK icon
3902
GeoPark
GPRK
$649M
$92.5K ﹤0.01%
+11,452
New +$103K
AVDL
3903
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
$90.8K ﹤0.01%
11,600
BACQR
3904
DELISTED
Inflection Point Acquisition Corp IV Right
BACQR
$90K ﹤0.01%
500,000
AHRT
3905
AH Realty Trust
AHRT
$534M
$90K ﹤0.01%
+11,980
New +$109K
NFE icon
3906
New Fortress Energy
NFE
$101M
$87.4K ﹤0.01%
10,512
-90
-0.8% -$1.11K
SANA icon
3907
Sana Biotechnology
SANA
$885M
$87.3K ﹤0.01%
+51,962
New +$145K
MRNOW
3908
Murano Global Investments PLC Warrants
MRNOW
$224K
$86.3K ﹤0.01%
375,000
NOEMR
3909
CO2 Energy Transition Corp Right
NOEMR
$84K ﹤0.01%
+280,000
New +$53.6K
FDMT icon
3910
4D Molecular Therapeutics
FDMT
$526M
$81.8K ﹤0.01%
25,340
-10,693
-30% -$50.4K
RSKD icon
3911
Riskified
RSKD
$672M
$81.3K ﹤0.01%
17,587
-43,502
-71% -$219K
PGACR
3912
Pantages Capital Acquisition Corp Right
PGACR
$81.3K ﹤0.01%
+325,000
New +$77.4K
INVE icon
3913
Identive
INVE
$64.6M
$80.9K ﹤0.01%
25,375
-56,932
-69% -$200K
KODK icon
3914
Kodak
KODK
$806M
$80.5K ﹤0.01%
12,738
-21,575
-63% -$150K
NKTR icon
3915
Nektar Therapeutics
NKTR
$2.39B
$78.3K ﹤0.01%
7,679
-4,001
-34% -$52.3K
LZM.WS icon
3916
Lifezone Metals Ltd Warrants
LZM.WS
$76.5K ﹤0.01%
166,366
VTYX
3917
DELISTED
Ventyx Biosciences
VTYX
$76.1K ﹤0.01%
66,193
+13,962
+27% +$24K
NOVA
3918
CALL
DELISTED
Sunnova Energy
NOVA
$72.5K ﹤0.01%
195,000
-268,900
-58% -$517K
RWT
3919
Redwood Trust
RWT
$616M
$72.4K ﹤0.01%
11,933
-81,079
-87% -$520K
ENGNW icon
3920
enGene Therapeutics Warrants
ENGNW
$3.75M
$67K ﹤0.01%
104,622
TBLA icon
3921
Taboola.com
TBLA
$1.32B
$66.1K ﹤0.01%
22,403
-192,639
-90% -$658K
FUFUW icon
3922
BitFuFu Inc Warrant
FUFUW
$66K ﹤0.01%
150,000
RANGR
3923
Range Capital Acquisition Corp Rights
RANGR
$65.3K ﹤0.01%
+375,000
New +$75.5K
BFLY.WS
3924
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$65.1K ﹤0.01%
723,004
ARKOW
3925
DELISTED
ARKO Corp Warrant
ARKOW
$63.8K ﹤0.01%
1,276,060

Similar funds

D.E. Shaw & Co's Q1 2025 Portfolio in Review

As of Q1 2025, D.E. Shaw & Co held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

D.E. Shaw & Co withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, D.E. Shaw & Co opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.

  • D.E. Shaw & Co's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
  • D.E. Shaw & Co added most to GE Vernova in Q1 2025, an estimated $686M increase.
  • D.E. Shaw & Co's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
  • D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
  • D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
  • D.E. Shaw & Co opened 569 new positions and closed 704 in Q1 2025.
  • D.E. Shaw & Co's portfolio value fell 18% quarter-over-quarter to $112B.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.